The changes observed in serum sTfR1 and GPX4 levels in stable COPD patients compared to non-COPD controls are consistent with the contributions of these two factors to mechanisms underlying ferroptosis, although need further studies. This evidence concerns the gene GPX4 and chronic obstructive pulmonary disease.